ENTITY
CSPC Pharmaceutical Group

CSPC Pharmaceutical Group (1093 HK)

222
Analysis
Health CareChina
CSPC Pharmaceutical Group Limited, through its subsidiaries, manufactures and sells pharmaceutical products. The Company's products include vitamin C, antibiotics and common generic drugs. The Company is also engages in the development of innovative drugs and antibiotics.
more
Refresh
24 Oct 2020 07:23

Asia Short Interest Weekly: Xiaomi, Evergrande, Toshiba, Asahi, NBF, Samsung, Hynix, TSMC, Acer

In Korea, shorts are throwing in the towel while short positions keep increasing in Taiwan. The report looks at stocks where there have been large...

Logo
325 Views
Share
14 Oct 2020 16:08

Simcere Pharmaceutical IPO: Valuation Insights

We think that an attractive PEG valuation and solid cornerstone support makes Simcere tempting at the proposed pricing range

Logo
468 Views
Share
10 Oct 2020 17:29

Simcere Pharmaceutical IPO Initiation: A Rough Patch?

The timing of the IPO is not ideal as Simcere is coming off a weak 1H20. However, Simcere is putting in place the right measures to ensure that the...

Logo
388 Views
Share
30 Sep 2020 16:24

CSPC Pharmaceutical Group Buy Target

CSPC Pharmaceutical Group (1093 HK) is seeing a rather well behaved pullback cycle that sets up a buy on weakness. Sell volumes have been light in...

Share
25 Jul 2020 10:01

Asia Short Interest Weekly: JD, Netease, CSPC, Alibaba, Meituan, Tencent, Fanuc, Mitsubishi, Toshiba

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
330 Views
Share
x